Pfizer (PFE) Said to Have Expressed Interest in Protalix (PLX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Protalix (PLX) Affirms Talks, Engages Citigroup as Advisor
February 5, 2013 11:45 AM ESTProtalix BioTherapeutics, Inc. (AMEX: PLX) confirms, in response to inquiries received this morning and a report appearing in the Israeli press, that the company has engaged Citigroup to assist it in reviewing a broad array of product partnering, technology sharing and other strategic... More
Protalix BioTherapeutics (PLX) for Sale at up to $1B - Report
February 5, 2013 9:04 AM ESTThe upside in Protalix BioTherapeutics, Inc. (NYSE: PLX) is related to reports the company is for sale for about $1 billion. Reports come from Calcalist.... More
Protalix BioTherapeutics, Inc. (PLX) Spikes Higher
February 5, 2013 8:56 AM ESTProtalix BioTherapeutics, Inc. (NYSE: PLX) sees sharp morning upside. Shares up 18%... More
